Cost-effectiveness of imatinib versus interferon-α plus...

Cost-effectiveness of imatinib versus interferon-α plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia

Shelby D. Reed, Kevin J. Anstrom, Jennifer A. Ludmer, G. Alastair Glendenning, Kevin A. Schulman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
101
Year:
2004
Language:
english
Pages:
10
DOI:
10.1002/cncr.20694
File:
PDF, 119 KB
english, 2004
Conversion to is in progress
Conversion to is failed